Novel Therapeutic Approaches for Myelodysplastic Syndromes: Going Beyond Hypomethylating Agents

Review expert guidance and clinical cases on the key data you need to know when managing patients with myelodysplastic syndromes.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Celgene